Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate in Alternating Hemiplegia of Childhood
NCT00931164Phase 2Completed
- Sponsor
- University of Utah
- Start
- Aug 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sodium oxybate in alternating hemiplegia of childhood (AHC), sponsored by University of Utah. Primary endpoints: Time Duration of AHC Episodes at Week 7, Observed Safety Data During 5-day Hospitalization for Drug Dose Identification at Week 7 and 1 more. Started Aug 2009; status: completed.
02
Drugs
sodium oxybate
03
Conditions
alternating hemiplegia of childhood (AHC)
Beyond the preview
Go deeper on NCT00931164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931164.